Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positron Emission Tomography (PET)”

2,481 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,481 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Early research (Phase 1)Ended earlyNCT03275974
What this trial is testing

Glutamine PET Imaging Colorectal Cancer

Who this might be right for
RAS Wild TypeStage IV Colorectal CancerStage IVA Colorectal Cancer+1 more
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT06335888
What this trial is testing

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

Who this might be right for
Giant Cell Arteritis
Insel Gruppe AG, University Hospital Bern 70
Not applicableUnknownNCT03447561
What this trial is testing

The Role of Consumption and Anticipation in Dopamine Release to Food Reward

Who this might be right for
HealthyFood Reward
Universitaire Ziekenhuizen KU Leuven 20
Not applicableUnknownNCT03942289
What this trial is testing

Human Aging and in Vivo Noradrenergic System

Who this might be right for
Parkinson Disease
Hospices Civils de Lyon 135
Not applicableActive Not RecruitingNCT02184013
What this trial is testing

Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study

Who this might be right for
Persistent Atrial Fibrillation
Ottawa Heart Institute Research Corporation 52
Not applicableUnknownNCT03830242
What this trial is testing

Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.

Who this might be right for
Positron-Emission TomographyLymph Node MetastasesThyroid Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT04199741
What this trial is testing

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Who this might be right for
Small Cell Lung CancerSmall Cell Lung Carcinoma
Memorial Sloan Kettering Cancer Center 105
Early research (Phase 1)Study completedNCT01266954
What this trial is testing

An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer

Who this might be right for
Solid Tumours
GlaxoSmithKline 36
Very early researchLooking for participantsNCT04861077
What this trial is testing

Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

Who this might be right for
Triple Negative Breast Cancer
University of Alabama at Birmingham 20
Testing effectiveness (Phase 2)Study completedNCT05160051
What this trial is testing

68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer

Who this might be right for
Tumor, Solid
University Hospital, Essen 158
Very early researchLooking for participantsNCT04499365
What this trial is testing

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

Who this might be right for
TumorPositron-Emission TomographyMetastasis
First Affiliated Hospital of Fujian Medical University 500
Testing effectiveness (Phase 2)Study completedNCT00343707
What this trial is testing

PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients

Who this might be right for
Depressive Disorder and Anxiety Disorders
GlaxoSmithKline 72
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03389100
What this trial is testing

Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

Who this might be right for
Diabetes Mellitus, Type 2Pre-diabetes
Columbia University 600
Not applicableStudy completedNCT01098045
What this trial is testing

HIV Fat Redistribution and the Evaluation of Brown Fat

Who this might be right for
HIV Infections
Massachusetts General Hospital 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT02827877
What this trial is testing

Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaStage IIIA Breast CancerStage IIIB Breast Cancer+1 more
City of Hope Medical Center 18
Post-approval studies (Phase 4)Study completedNCT02234492
What this trial is testing

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)Cardiovascular Disease (CVD)
Ottawa Heart Institute Research Corporation 35
Not applicableLooking for participantsNCT06305728
What this trial is testing

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

Who this might be right for
Pancreatic Cyst
Memorial Sloan Kettering Cancer Center 25
Not applicableEnded earlyNCT02237677
What this trial is testing

CB1 Receptor PET Imaging Reveals Gender Differences in PTSD

Who this might be right for
Post-traumatic Stress Disorder (PTSD)
NYU Langone Health 36
Not applicableUnknownNCT00297557
What this trial is testing

Dual Time Point PET Imaging in Lymphoma

Who this might be right for
Hodgkin's or Non-Hodgkin's Lymphoma
Royal Marsden NHS Foundation Trust
Next Page